COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Sheba Medical Center Home Monitoring Clinic Registry

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01154205
Recruitment Status : Unknown
Verified June 2010 by Sheba Medical Center.
Recruitment status was:  Not yet recruiting
First Posted : June 30, 2010
Last Update Posted : June 30, 2010
Information provided by:
Sheba Medical Center

Brief Summary:
The purpose of the registry is to assess workload of a Home Monitoring based follow up for Biotronik ICD and CRTD patients.

Condition or disease
Clinical Workload Assessment Based Upon a Home Monitoring System

Layout table for study information
Study Type : Observational
Estimated Enrollment : 100 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Sheba Medical Center Home Monitoring Clinic Registry
Study Start Date : June 2010
Estimated Study Completion Date : January 2012

Patients post implantation of ICD or CRTD

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients implanted with an ICD or CRTD.

Inclusion Criteria:

  • Approved indication for ICD or CRTD
  • Implanted with or replaced with a Biotronik Lumax device
  • Patient willing and able to sign consent form
  • Willing and able to attend clinic visits and follow up schedule
  • Transmission of more than 80% at 3-month follow up
  • Patient older than 18 years

Exclusion Criteria:

  • no indication for ICD or CRTD implant
  • Life expectancy shorter than 12 months
  • Pregnancy
  • Participation in other clinical studies

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01154205

Layout table for location contacts
Contact: David Luria, MD 972-52-6667111

Layout table for location information
Sheba Medical Center
Tel HaShomer, Ramat Gan, Israel, 52621
Principal Investigator: David Luria, MD         
Sub-Investigator: Michael Glikson, Professor         
Sub-Investigator: David Bar Lev, MD         
Sub-Investigator: Osnat Gurevitz, MD         
Sponsors and Collaborators
Sheba Medical Center
Layout table for additonal information
Responsible Party: Dr. David Luria, Heart Center at Sheba Medical Center Identifier: NCT01154205    
Other Study ID Numbers: SHEBA-09-7598-DL-CTIL
First Posted: June 30, 2010    Key Record Dates
Last Update Posted: June 30, 2010
Last Verified: June 2010